226 related articles for article (PubMed ID: 34086694)
41. Ezetimibe Use and LDL-C Goal Achievement: A Retrospective Database Analysis of Patients with Clinical Atherosclerotic Cardiovascular Disease or Probable Heterozygous Familial Hypercholesterolemia.
Menzin J; Aggarwal J; Boatman B; Yu J; Stern K; Harrison DJ; Patel JG
J Manag Care Spec Pharm; 2017 Dec; 23(12):1270-1276. PubMed ID: 29172973
[TBL] [Abstract][Full Text] [Related]
42. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
Farnier M; Salignon-Vernay C; Yao H; Chague F; Brunel P; Maza M; Brunet D; Bichat F; Beer JC; Cottin Y; Zeller M
J Clin Lipidol; 2019; 13(4):601-607. PubMed ID: 31324593
[TBL] [Abstract][Full Text] [Related]
43. Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
Barkas F; Rizos CV; Liamis G; Skoumas I; Garoufi A; Rallidis L; Kolovou G; Tziomalos K; Skalidis E; Sfikas G; Kotsis V; Doumas M; Anagnostis P; Lambadiari V; Anastasiou G; Koutagiar I; Attilakos A; Kiouri E; Kolovou V; Polychronopoulos G; Koutsogianni AD; Zacharis E; Koumaras C; Antza C; Boutari C; Liberopoulos E
J Clin Lipidol; 2024; 18(3):e394-e402. PubMed ID: 38331687
[TBL] [Abstract][Full Text] [Related]
44. Association of reproductive factors with the incidence of breast cancer in Gulf Cooperation Council countries.
Ravichandran K; Al-Zahrani AS
East Mediterr Health J; 2009; 15(3):612-21. PubMed ID: 19731777
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction.
Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H
Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778
[TBL] [Abstract][Full Text] [Related]
46. Management of Familial Hypercholesterolemia in Hong Kong.
Hu M; Hooper AJ; Bockxmeer FM; Watts GF; Chan JC; Tomlinson B
J Atheroscler Thromb; 2016 May; 23(5):520-31. PubMed ID: 26875521
[TBL] [Abstract][Full Text] [Related]
47. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
[TBL] [Abstract][Full Text] [Related]
48. The tertiary hospital laboratory; a novel avenue of opportunistic screening of familial hypercholesterolemia.
Mirzaee S; Choy KW; Doery JCG; Zaman S; Cameron JD; Nasis A
Int J Cardiol Heart Vasc; 2019 Jun; 23():100354. PubMed ID: 31080874
[TBL] [Abstract][Full Text] [Related]
49. Familial hypercholesterolemia in a large ambulatory population: Statin use, optimal treatment, and identification for advanced medical therapies.
Knickelbine T; Lui M; Garberich R; Miedema MD; Strauss C; VanWormer JJ
J Clin Lipidol; 2016; 10(5):1182-7. PubMed ID: 27678435
[TBL] [Abstract][Full Text] [Related]
50. Management of High and Very High-Risk Subjects with Familial Hypercholesterolemia: Results from an Observational Study in Bulgaria.
Petrov IS; Postadzhiyan AS; Tokmakova MP; Kitova LG; Tsonev SN; Addison J; Petkova RT; Lachev VI
Folia Med (Plovdiv); 2018 Sep; 60(3):389-396. PubMed ID: 30355848
[TBL] [Abstract][Full Text] [Related]
51. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and Treatment of Familial Hypercholesterolemia in France.
Bérard E; Bongard V; Haas B; Dallongeville J; Moitry M; Cottel D; Ruidavets JB; Ferrières J
Can J Cardiol; 2019 Jun; 35(6):744-752. PubMed ID: 31151710
[TBL] [Abstract][Full Text] [Related]
53. Efficiency and problems of statin therapy in patients with heterozygous familial hypercholesterolemia.
Korneva V; Kuznetsova T; Julius U
Atheroscler Suppl; 2019 Dec; 40():79-87. PubMed ID: 31818452
[TBL] [Abstract][Full Text] [Related]
54. Familial Hypercholesterolemia: Advances in Recognition and Therapy.
Cartier JL; Goldberg AC
Prog Cardiovasc Dis; 2016; 59(2):125-134. PubMed ID: 27477957
[TBL] [Abstract][Full Text] [Related]
55. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.
Vlad CE; Foia L; Florea L; Costache II; Covic A; Popescu R; Reurean-Pintilei D; Covic A
Lipids Health Dis; 2021 Jan; 20(1):4. PubMed ID: 33430859
[TBL] [Abstract][Full Text] [Related]
57. Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care.
Balla S; Ekpo EP; Wilemon KA; Knowles JW; Rodriguez F
Curr Atheroscler Rep; 2020 Aug; 22(10):60. PubMed ID: 32816232
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis and treatment of familial hypercholesterolaemia.
Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM
Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
[TBL] [Abstract][Full Text] [Related]
59. Proprotein convertase subtilisin/kexin 9 inhibition in patients with familial hypercholesterolemia: Initial clinical experience.
Galema-Boers AMH; Lenzen MJ; Sijbrands EJ; Roeters van Lennep JE
J Clin Lipidol; 2017; 11(3):674-681. PubMed ID: 28506389
[TBL] [Abstract][Full Text] [Related]
60. Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors.
Razek O; Cermakova L; Armani H; Lee T; Francis GA; Mancini GBJ; Frohlich J; Brunham LR
Can J Cardiol; 2018 Aug; 34(8):1004-1009. PubMed ID: 30056842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
